Intravenous Ibuprofen Market Buoyed By Latest Impr
Post# of 301275
Wilmington, Delaware, United States, March 25, 2017 (GLOBE NEWSWIRE) -- The report “ World Intravenous (IV) Ibuprofen Market - Opportunities and Forecast 2022 ”, available on MarketIntelReports, estimates that the market will register a CAGR of 20% till 2022.
Browse numerous Market Tables as well as Figures which are spread through 65 Pages and an in-depth TOC on the “ Intravenous Ibuprofen Market Forecast 2022 ” http://www.marketintelreports.com/report/alli...2015--2022
Scope & Regional Forecast of the Intravenous Ibuprofen Market
Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness. The intravenous (IV) route for ibuprofen administration has a faster onset of action as compared to the other routes. IV ibuprofen is preferred for the management of post-operative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics such as respiratory depression, allergic reactions, sedation, and gastrointestinal events.
Request Sample PDF Brochure @ http://www.marketintelreports.com/pdfdownload...allied0083
The market for IV ibuprofen for pain management is in its nascent stage. Advantages associated with IV ibuprofen such as rapid result and targeted drug delivery have resulted in the growth of this market. In 2015, FDA approved IV ibuprofen for pediatric use, due to which the market is expected to register a significant growth during the forecast period. Other factors that affect the market growth significantly include increasing incidence of cancer, cardiovascular ailments, pain, headache, toothache, back pain, arthritis, trauma, and shifting trend towards the use of non-opioids drugs. Factors that would hamper the market growth include side effects associated with IV ibuprofen and lengthy approval process. Intravenous (IV) Ibuprofen Market is expected to garner $14.2 million by 2022, registering a CAGR of 20.0% during the forecast period 2015-2022.
Inquiry before buying report @ http://www.marketintelreports.com/inquiry-bef...allied0083
Prominent Segmentations Involved in the Intravenous Ibuprofen Market
The Intravenous Ibuprofen Market can be broken down into various segmentations on the basis of -
- Age Group : Pediatrics and Adults.
- Indication : Pain and Fever.
- Country : United States, Canada, Australia and South Korea.
Some of the sample companies profiled in the Intravenous Ibuprofen Market report are as follows :
- Cumberland Pharmaceuticals Inc.
- Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.)
- CSL Limited
- Sandor Medicaids Pvt Ltd.
- PT. Soho Industri Pharmasi
- Germin MED
- Grifols S.A.
Why buy this report?
- Get a detailed picture of the Intravenous Ibuprofen Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase Intravenous Ibuprofen Market Report @ http://www.marketintelreports.com/purchase.php?id=allied0083
About Us:
MarketIntelReports (MIR) aims to empower our clients to successfully manage and outperform in their business decisions. We do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
MarketIntelReports currently has more than 150,000 plus titles and 100+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Media Contact:
Company Name: Market Intel Reports Contact Person: Mayur S Email: sales@marketintelreports.com Phone: 1-302-261-5343 Address: 2712 Centerville Road, Suite 400 City: Wilmington State: Delaware Country: United States
(0)
(0)